Cognitive Enhancement Protocol

Overview

Nootropic peptides represent a class of compounds that have been studied for their effects on cognitive function, neuroprotection, and brain-derived neurotrophic factor (BDNF) expression. Unlike traditional nootropics (racetams, stimulants), peptide-based cognitive enhancers work through neurotrophin modulation, receptor sensitization, and direct neuroprotective mechanisms.

The three most commonly referenced nootropic peptides are Semax, Selank, and Dihexa. Each has a distinct mechanism of action, and they are often combined in protocols targeting different aspects of cognitive performance — focus, anxiety reduction, memory formation, and long-term neuroprotection.

A notable feature of this protocol category is that the primary administration route for Semax and Selank is intranasal rather than injection, making these among the most accessible peptides in terms of ease of use.

Compounds Involved

Semax

Semax is a synthetic heptapeptide derived from the ACTH (adrenocorticotropic hormone) fragment 4-10, with a modified C-terminal tripeptide (Pro-Gly-Pro) that improves stability and bioavailability. Developed at the Institute of Molecular Genetics in Russia, Semax has been studied for its effects on BDNF and nerve growth factor (NGF) expression, dopaminergic and serotonergic system modulation, and cognitive performance under stress.

Semax is available in several forms, including the standard version and the N-Acetyl (NA) Semax and NA-Semax-Amidate variants, which have enhanced potency and duration.

Selank

Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, with an added Gly-Pro sequence for stability. It was developed alongside Semax at Russian research institutions and has been studied primarily for its anxiolytic (anti-anxiety) and nootropic properties. Selank modulates GABA-ergic neurotransmission without the sedation, tolerance, or dependence associated with benzodiazepines.

Like Semax, Selank is available in standard and enhanced forms (NA-Selank, NA-Selank-Amidate).

Dihexa

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small peptide derived from angiotensin IV that was developed at Washington State University. It is notable for its potency — research has shown it to be approximately seven orders of magnitude more potent than BDNF in promoting hepatocyte growth factor (HGF) signaling, which plays a role in synaptogenesis and memory formation.

Due to its potency and limited long-term safety data, Dihexa is typically used at very low doses and for shorter durations than Semax or Selank.

Protocol Structure

Beginner: Semax or Selank Monotherapy (Weeks 1–8)

For those new to nootropic peptides, starting with a single compound allows for baseline assessment of individual response.

Semax focus protocol:

• Dose: 200–400 mcg per day
• Route: Intranasal (1–2 sprays per nostril, depending on concentration)
• Timing: Morning, or 30 minutes before demanding cognitive work
• Duration: 4–8 weeks

Selank calm-focus protocol:

• Dose: 200–400 mcg per day
• Route: Intranasal
• Timing: Morning, or during periods of elevated stress/anxiety
• Duration: 4–8 weeks

Intermediate: Semax + Selank Stack (Weeks 1–12)

Combining Semax and Selank addresses both the activating (focus, BDNF) and calming (anxiolysis, GABA) dimensions of cognitive performance.

Daily protocol:

• Administer Semax and Selank at least 15 minutes apart to allow full mucosal absorption of each
• Avoid blowing nose for 10–15 minutes after administration
• Duration: 8–12 weeks, followed by a 2–4 week break

Advanced: Full Nootropic Stack (Weeks 1–8)

This protocol adds Dihexa to the Semax/Selank base for enhanced synaptogenesis and memory support.

Daily protocol:

• Duration: 4–8 weeks maximum for the Dihexa component (limited long-term safety data)
• Semax and Selank can continue for 8–12 weeks
• Follow with a 4-week break from all compounds

Intranasal Administration Tips

For detailed technique, see Intranasal Administration. Key points specific to this protocol:

• Clear nasal passages before administration (gentle saline rinse if needed)
• Tilt head slightly forward during administration to keep the solution on the nasal mucosa
• Alternate nostrils with each spray to maximize surface area contact
• Do not sniff aggressively — a gentle inhalation is sufficient
• Store nasal spray bottles in the refrigerator between uses

Enhanced Variants

Both Semax and Selank are available in modified forms with increased potency:

When using enhanced variants, reduce doses proportionally based on the estimated potency increase.

Important Considerations

• Individual variation is significant: Cognitive peptides produce highly variable responses. Some individuals report dramatic improvements in focus or verbal fluency, while others notice subtle or no changes. Maintaining a cognitive journal can help identify real effects versus placebo.
• Dihexa caution: Due to limited long-term safety data and high potency, Dihexa should be approached conservatively. Shorter cycles (4–8 weeks) with extended breaks are the norm.
• Not stimulants: These peptides do not produce the acute, obvious effects of caffeine or amphetamines. Effects are often described as a gradual "clearing" or "sharpening" rather than an energy spike.
• Sleep quality matters: Cognitive peptides work best within the context of adequate sleep. Consider combining with the Sleep Optimization Protocol for synergistic effects.
• Cycling: Semax and Selank are commonly cycled 8–12 weeks on / 2–4 weeks off. Dihexa cycles are shorter (4–8 weeks on / 4+ weeks off). See Peptide Cycling.
• Quality assessment: Nootropic peptides are particularly susceptible to quality variation. Third-party testing and COA verification are strongly recommended. See Quality Assessment.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical advice, and no therapeutic claims are made. Peptide research is ongoing, and individual outcomes may vary. Consult a qualified healthcare professional before beginning any peptide protocol. All compounds discussed are intended for research purposes.